Citation Impact
Citing Papers
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
2016
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Parenteral Anticoagulants
2008
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
2008
Parenteral Anticoagulants
2012 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys
2010
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
2004 StandoutNobel
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Acute ST-Segment Elevation Myocardial Infarction
2008
Argatroban for anticoagulation during cardiac surgery
2006
Calibration Verification of the International Normalized Ratio
1996
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Wnt signaling in cancer
2016 Standout
Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?
2002
Silent deep vein thrombosis in immobilized multiple trauma patients
1989
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Heparin and Low-Molecular-Weight Heparin
2004
Heparin-Induced Thrombocytopenia
2006 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Apparent heparin resistance from elevated factor VIII during pregnancy
2000
Cockayne syndrome: Review of 140 cases
1992
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
How were new medicines discovered?
2011 Standout
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
2011
Liposome transduction into cells enhanced by haptotactic peptides (Haptides) homologous to fibrinogen C-termini
2004
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time
2008
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Apoptosis regulation in tetraploid cancer cells
2006
von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1
2008
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
2008
Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants
2014
Thromboembolic Phenomena and the use of the Pig as an Appropriate Animal Model for Research on Cardiovascular Devices
1997 StandoutNobel
Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini‐review
2020
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Yeast Nucleotide Excision Repair Proteins Rad2 and Rad4 Interact with RNA Polymerase II Basal Transcription Factor b (TFIIH)
1994 StandoutNobel
Guidelines for the Primary Prevention of Stroke
2014 Standout
Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II
2000
Delayed-Onset Heparin-Induced Thrombocytopenia
2002
Yeast nucleotide excision repair proteins Rad2 and Rad4 interact with RNA polymerase II basal transcription factor b (TFIIH).
1994 StandoutNobel
Lipid peroxidation in platelet concentrates: effects of leukocyte removal by filtration.
1994
Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors
2006
Multicenter Evaluation of Lyophilized and Deep-frozen Plasmas for Assignment of the International Normalized Ratio
1999 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
1998
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
2000
Correlation of Antifactor Xa Concentrations with Renal Function in Patients on Enoxaparin
2003
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Guidelines for the management of hemophilia
2012 Standout
Investigation and management of heritable thrombophilia
2001
Deep Venous Thrombosis and Pulmonary Embolism in Trauma Patients
1988
Recommendations for Evaluation of Coagulation Analyzers
2006
Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction
2009
Cockayne syndrome group B protein enhances elongation by RNA polymerase II
1997 StandoutNobel
Works of Mark T. Cunningham being referenced
College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy
1998
Laboratory Reporting of the International Normalized Ratio: Progress and Problems
2007
Laboratory Diagnosis of Dysfibrinogenemia
2002
Biphasic Acute Myeloid Leukemia With Near-Tetraploidy and Immunophenotypic Transformation
2004
A Method for Proficiency Testing of Small Peer Groups in the College of American Pathologists Coagulation Surveys
1999
Effect of Fondaparinux on Coagulation Assays: Results of College of American Pathologists Proficiency Testing
2006
External Peer Review Quality Assurance Testing in von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing Program
2006
The Reliability of Manufacturer-determined, Instrument-specific International Sensitivity Index Values for Calculating the International Normalized Ratio
1994
Evidence of a Phospholipid Binding Species within Human Fibrinogen Preparations
1999
Abnormal Wnt signaling and stem cell activation in reactive lymphoid tissue and low-grade marginal zone lymphoma
2010
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
The role of membrane lipid in the platelet storage lesion.
1992
Vascular spasm and gangrene during heparin–dihydro-ergotamine prophylaxis
1984
Cockayne's syndrome and emphysema.
1978
Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction
1985